Results 161 to 170 of about 1,506,029 (346)
Background Globally, non-fatal overdose (NFOD) rates consequent to drug use, typically opioids, continue increasing at a startling rate. Existing quantitative research has revealed myriad factors and characteristics linked to experiencing NFOD, but it is
Christopher J. Byrne +3 more
doaj +1 more source
Estimating the population size of people who inject drugs in Canada, 2021.
BACKGROUND: People who inject drugs are disproportionately affected by HIV and hepatitis C infections. Estimating the size and distribution of this population is essential in monitoring infectious diseases rates and progress towards elimination ...
Williams, Anson +7 more
core +1 more source
Contextualising multimorbidity in people who use drugs: analysis of drug-death decedents in Scotland
Abstract Objectives: To characterise hospital-treated multimorbidity patterns in people who subsequently died a drug-related death in Scotland, and to identify clinically meaningful associations among conditions and decedent to inform prevention and care.
Joe Schofield +8 more
openaire +3 more sources
Flexible silicon carbide (SiC) microelectrode arrays enable high‐fidelity, multichannel cell extracellular recording and precise localized ablation. SiC has been extensively evaluated to persist long‐term in chronic physiological conditions while remaining robust, with excellent electrical and electrochemical stability.
Minh Anh Huynh +4 more
wiley +1 more source
Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
HIV and drugs: a common, common-sense agenda for 2016
Kent Buse +2 more
doaj +1 more source
This report documents the lived-living experiences of overdose among people who use drugs in Queensland, Australia. The findings underscore an urgent need for comprehensive harm reduction strategies, including post-prison transitions, supervised drug ...
Kill, Emma +2 more
core
Our study identifies the HDACs‐STAT3 axis as key regulator for M2 macrophage accumulation in DLBCL. We developed Chid@M2pep‐EVs/TP, a pH‐responsive drug delivery system for M2 macrophage specific chidamide administration. By coupling M2‐targeted chidamide with EVs‐mediated delivery, this system reprograms M2 to M1 via HDAC inhibition and STAT3 ...
Bo Dai +15 more
wiley +1 more source
Psychosocial consequences of xylazine and implications for harm reduction services
Introduction: Xylazine, a veterinary tranquilizer not approved for human use, has increasingly contaminated the unregulated drug supply in the United States and is a key driver of an increasingly synthetic, polysubstance overdose crisis.
Marina Plesons +10 more
doaj +1 more source
How stigmatising language affects people in Australia who use tobacco, alcohol and other drugs.
BACKGROUND: Use of tobacco, alcohol and other drugs (TAOD) is common in Australia and can cause high morbidity and mortality. It is not uncommon for people who use TAOD to experience stigma when accessing healthcare, including general practice.
Wilson, Hester
core

